Drug Targets In-Depth Focus 2012
In this Drug Targets In-Depth Focus: GPCR allosteric modulation: new opportunities and challenges for drug discovery; Chloride channels and cardiac arrhythmia: novel therapeutic targets?
List view / Grid view
In this Drug Targets In-Depth Focus: GPCR allosteric modulation: new opportunities and challenges for drug discovery; Chloride channels and cardiac arrhythmia: novel therapeutic targets?
6 December 2012 | By Ballou PR
Distribution agreement...
25 September 2012 | By Cisbio Bioassays
Cisbio Bioassays announces the launch of its epigenetics toolbox for use in drug discovery research...
10 May 2012 | By Ballou PR
Company combines expertise in assay design with its powerful HTRF® technology...
26 March 2010 | By
Cisbio Bioassays (www.htrf.com), a member of IBA group and global developer of HTRF® (Homogeneous Time-Resolved Fluorescence) technology and services used in assay development and drug screening, announced that it has introduced six multi-mode cell lines to its expanding Tag-lite® cellular platform...